drugset / Trial / NCT00151138

Cognitive/Cerebrovascular Consequences of HTN Treatment

NCT00151138

RandomizedParallel-groupDouble-blindTreatment

Summary

Randomized trial of two antihypertensive drugs of known efficacy to investigate whether one has more favorable effects on brain blood flow and cognitive function.

Timeline

Start
2002-09
Primary completion
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Atenolol Other / unclassified
Subject LISINOPRIL ANHYDROUS Small molecule

Indications